企業プロフィール
Biodesix 株価・ニュース・カタリスト
- ティッカー:
- BDSX
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United States
株価パフォーマンス
23.25 USD (-3.13%)
終値
最終更新: 2026年8月17日
160M USD
時価総額
株価変動の要因
As of Aug 17, 2026, BDSX closed down 3.13% at $23.25. No new same-company headline was identified in the current news window.
企業概要
Lung-Disease Diagnostics
Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology. Its tests combine multiple analytical technologies with clinical evidence and laboratory operations.
Diagnostic Testing
The company provides blood-based and other diagnostic tests that help physicians characterize disease, guide treatment and monitor patients. Its commercial laboratory infrastructure supports ordering, sample processing and reporting for routine clinical use.
Development Services
Biodesix also works with biopharmaceutical, life-sciences and research organizations to develop diagnostics, tools and therapeutics. These services combine scientific, technological and operational capabilities and can support biomarker strategy from research through clinical development.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。